Entering text into the input field will update the search result below

Cesca Therapeutics reports FQ2 results

Feb. 13, 2017 4:09 PM ETThermoGenesis Holdings, Inc. (THMO) StockBy: Mohit Manghnani, SA News Editor
  • Cesca Therapeutics (KOOL): FQ2 Net loss of $3.4M.
  • Revenue of $4M (+21.2% Y/Y)
  • Shares +6.9%.
  • Press Release

Recommended For You

More Trending News

About THMO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
THMO--
ThermoGenesis Holdings, Inc.